Clinical Trials
3
Active:0
Completed:2
Trial Phases
3 Phases
Phase 1:1
Phase 2:1
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)β’ Click on a phase to view related trials
Phase 1
1 (33.3%)Phase 2
1 (33.3%)Phase 3
1 (33.3%)The Prevent Severe COVID-19 (PRESECO) Study
- First Posted Date
- 2020-10-23
- Last Posted Date
- 2024-03-29
- Lead Sponsor
- Appili Therapeutics Inc.
- Target Recruit Count
- 1187
- Registration Number
- NCT04600895
- Locations
- πΊπΈ
Cahaba Research, Inc., Pelham, Alabama, United States
πΊπΈAbsolute Clinical Research, Phoenix, Arizona, United States
πΊπΈB.G Clinical Research Center, LLC, Little Rock, Arkansas, United States
Control of COVID-19 Outbreaks in Long Term Care
Phase 2
Terminated
- Conditions
- COVID-19SARS-CoV-2
- Interventions
- First Posted Date
- 2020-06-25
- Last Posted Date
- 2023-02-21
- Lead Sponsor
- Appili Therapeutics Inc.
- Target Recruit Count
- 67
- Registration Number
- NCT04448119
- Locations
- π¨π¦
Mount Sinai Hospital, Toronto, Ontario, Canada
Bioavailability of ATI-1501 With Taste Test Sub Study
- First Posted Date
- 2017-11-08
- Last Posted Date
- 2019-01-11
- Lead Sponsor
- Appili Therapeutics Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT03337126
- Locations
- π¨π¦
INC Research Inc., Toronto, Ontario, Canada
News
No news found